Evidence map›Paper›PMID 32885148›Full record

ArticleHemaSphere2020

Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura.

Leydi C Velasquez Pereira, Bogac Ercig, Kadri Kangro, Matthieu Jamme, Sandrine Malot, Lionel Galicier, Pascale Poullin, François Provôt, Claire Presne, Tarik Kanouni and 7 more

Open access · goldAbstract read
In one paragraph

Article in HemaSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 14 institutions in 3 countries.

Leydi C Velasquez PereiraLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
Bogac ErcigDepartment of Plasma Proteins, Sanquin-Academic Medical Center Landsteiner Laboratory, Amsterdam, the Netherlands.
Kadri KangroLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
Matthieu JammeMédecine Intensive Réanimation-Néphrologie, CH de Poissy Saint Germain en Laye, Poissy, Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Paris-Sud University, Villejuif, France.
Sandrine MalotCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
Lionel GalicierCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
Pascale PoullinCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
François ProvôtCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
Claire PresneCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
Tarik KanouniCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
Aude ServaisCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
Ygal BenhamouCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
Nicolas DaguindauService d'Hématologie, CH d'Annecy, France.
Karen VanhoorelbekeLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
Elie AzoulayCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
Agnès VeyradierCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
Paul CoppoCentre de Référence des Microangiopathies Thrombotiques, AP-HP.6, Paris, France.
KU Leuven · BEAcademic Medical Center · NLCentre de recherche en Epidémiologie et Santé des Populations · FRCentre Hospitalier Universitaire Amiens-Picardie · FRDélégation Paris 7 · FRHôpital Albert Calmette · FRHôpital de la Conception · FRHôpital Necker-Enfants Malades · FRHôpital Saint Eloi · FRInserm · FRInstitut de recherche Saint-LouisNormandie Université · FRResearch Institute for Chromatography · BESorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following an acute thrombotic thrombocytopenic purpura (TTP) episode, patients are at risk for relapse, and a careful long-term follow-up is needed. Adherence to the follow-up by patients implies a good understanding of the disease. However, TTP literacy in patients is currently unknown. To explore the TTP literacy in patients and identify factors associated with poor disease understanding, a questionnaire was developed focusing on patient's characteristics, knowledge about TTP and patients' actions in an emergency. The questionnaire was presented to 120 TTP patients in remission from the French National Registry for Thrombotic Microangiopathies. TTP literacy was low in 24%, intermediate in 43% and high in 33% of the patients. Low TTP literacy was associated with older age and low education level. Among the knowledge gaps identified, few patients knew that plasma exchange in acute phase is mandatory and has to be done daily (39%), 47% of participants did not consider themselves at risk for relapse, and 30% of women did not know that pregnancy exposes them to a greater risk of relapse. Importantly, few patients responded about life-saving actions in an emergency. Hence, the design of educational material should pay special attention to the age and education level of the target population focusing on the events leading to TTP, the importance of the emergency treatment, controllable predisposing factors for TTP development and patient attitude in an emergency.

Identifiers

PMID32885148
PMCPMC7430230
OpenAlexW3048553063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.